This guidance for the management of patients with allergic and non‐allergic rhinitis has
been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy …

This is an updated guideline for the diagnosis and management of allergic and non‐allergic
rhinitis, first published in 2007. It was produced by the Standards of Care Committee of the …

Allergic rhinitis (AR) affects more than 20% of the population in the United Kingdom and
western Europe and represents a major cause of morbidity that includes interference with …

Rhinitis is a common problem in primary care which is often managed sub-optimally. It
causes considerable morbidity and has been shown to have a detrimental impact on …

This document provides healthcare practitioners with information regarding the
management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them …

Future management guidelines for allergic rhinitis must take into account the results of this
survey. Such guidelines must promote relief from the emotional burden of allergic rhinitis …

Allergen‐specific immunotherapy is one of the cornerstones of allergic rhinoconjunctivitis
treatment. Since the development of non‐invasive administration forms with better safety …

The association between the upper and lower airways has been recognised for almost 2000
years. Epidemiological data suggest that most asthma patients also suffer from allergic …

The incidence of allergic rhinitis has been increasing for the last few decades, in keeping
with the rising incidence of atopy worldwide. Allergic rhinitis has a prevalence of up to 40 …

BACKGROUND: Allergic rhinitis represents a global health problem affecting 10% to 20% of
the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been …